Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urine C-peptide, beta-cell function, and insulin requirement

E B Rappaport, R A Ulstrom, D D Etzwiler

    American Journal of Diseases of Children (1960)
    |December 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India.

    PloS one·2023
    Same author

    The Effects of Policy-Driven Air Quality Improvements on Children's Respiratory Health.

    Research report (Health Effects Institute)·2020
    Same author

    Erratum: (1) Pediatric Obesity and Cardiometabolic Disorders: Risk Factors and Biomarkers.

    EJIFCC·2018
    Same author

    Pediatric Obesity and Cardiometabolic Disorders: Risk Factors and Biomarkers.

    EJIFCC·2017
    Same author

    A need to know.

    The Physician and sportsmedicine·2016
    Same author

    Kidney transplant donor glomerular filtration rate by iohexol clearance during computerized tomographic angiography of the kidneys.

    Transplantation proceedings·2013

    Urinary C-peptide excretion monitoring helps assess beta-cell function in diabetic patients. This simple method tracks endogenous insulin production, aiding in diabetes management and understanding treatment effectiveness.

    Area of Science:

    • Endocrinology
    • Metabolic Diseases
    • Clinical Chemistry

    Background:

    • Beta-cell dysfunction is central to diabetes mellitus.
    • Monitoring endogenous insulin production is crucial for effective diabetes management.
    • Current methods for assessing beta-cell function can be invasive or complex.

    Purpose of the Study:

    • To evaluate urinary C-peptide excretion as a non-invasive marker for beta-cell function in diabetic patients.
    • To correlate urinary C-peptide levels with endogenous insulin production and diabetic control.
    • To assess the utility of urinary C-peptide in monitoring recovery of beta-cell function.

    Main Methods:

    • Measurement of urinary C-peptide excretion in healthy controls and diabetic patients.
    • Correlation analysis of urinary C-peptide levels with serum C-peptide and insulin secretion.

    Related Experiment Videos

  • Serial monitoring of urinary C-peptide in patients with diabetic ketoacidosis.

    • Main Results:

    • Urinary C-peptide excretion in controls correlated with insulin secretion.
    • Diabetic patients on high insulin doses showed low C-peptide excretion; those with low insulin needs had near-normal levels.
    • Recovery of beta-cell function was observed via C-peptide measurements in patients treated for ketoacidosis.

    Conclusions:

    • Urinary C-peptide excretion is a simple and valuable tool for assessing endogenous insulin production in diabetic patients.
    • This method can aid in monitoring beta-cell function and guiding treatment strategies.
    • Urinary C-peptide measurement offers a practical approach for clinical use in diabetes care.